Halozyme Therapeutics Inc (HALO)

[maumar]

Let's play devil's advocate. What other reasons could there be for the delay?

The only negative in the report was Pfizer dropping two programs. Royalties are still growing but not as quickly as I would like. Is it because there are still no bio-similars in the major markets and Roche does not have enough of an incentive to push Halo's SC formulations?

I'm hoping to see a filing of Herceptin SC in the US soon because of this:

"Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced submission of Mylan's biologics license application (BLA) for MYL-1401O, a proposed biosimilar trastuzumab, to the U.S. Food and Drug Administration (FDA) through the 351(K) pathway."

https://finance.yahoo.com/news/mylan-biocon-announce-u-fda-123000423.html

The last slide in the presentation tells us again that we should get some more good news before Christmas.